Frontlight ResearchEarly access
Metastatic breast cancer trials in Russia
2 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1
- Where
- Kazan', Krasnoyarsk, Moscow, Saint Petersburg, Ufa
- Age
- 18 years and over
- People
- 64
- Run by
- Kidney Cancer Research Bureau
See details and how to joinNCT07292168 - Phase 3Not yet taking people in RussiaClinical Trial Protocol: Randomized Placebo-Controlled Pilot Study of GcMAF (Soloways TM) in Patients With Metastatic Breast Cancer
- Where
- Novosibirsk
- Age
- 18 years to 80 years
- People
- 60
- Run by
- S.LAB (SOLOWAYS)
See details and how to joinNCT06434077